Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy
NCT ID: NCT00634998
Last Updated: 2023-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
10 participants
INTERVENTIONAL
2007-11-30
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Vitamin D in Patients With Diabetic Peripheral Neuropathy to Alleviate Pain and Improvement of Symptoms
NCT04984044
A Nutritional Intervention for Diabetic Neuropathy
NCT01690962
A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy
NCT04005287
Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy
NCT00760955
Cognitive Behavioral Therapy for Diabetic Neuropathic Pain
NCT00829387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2
1000mg Placebo capsules orally twice daily for 90 days
Placebo
1000mg Placebo capsules orally twice daily for 90 days
1
1000mg Vitamin C capsules orally twice daily for 90 days
Vitamin C
1000mg Vitamin C capsules orally twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin C
1000mg Vitamin C capsules orally twice daily
Placebo
1000mg Placebo capsules orally twice daily for 90 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diabetic peripheral neuropathy
* A1C of 6.0-10.0%
Exclusion Criteria
* Dementia
* Anemia
* Significant renal dysfunction
* History of B-12 deficiency
* Peripheral vascular disease
* Current smoker
* History of kidney stones
* Current ascorbic acid use
* Presence or foot infection and/or ulcer
50 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joshua Neumiller
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua J Neumiller, PharmD
Role: PRINCIPAL_INVESTIGATOR
Washington State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington State University, College of Pharmacy, Department of Pharmacotherapy
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06H-2958-9918
Identifier Type: -
Identifier Source: secondary_id
10046-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.